Economic valuation of the costs and benefits of regulatory action is often required before legislation on hazardous chemicals is passed. However, such valuation is complicated by data limitations, information asymmetries and substantial uncertainties regarding for example doseresponse relationships. This workshop brought together experts from regulatory agencies and academia to identify what we regard today as good practice in economic valuation of chemicals and outline an agenda for further research and improved practice.
Read the full report (will be downloaded):